Grace Therapeutics Inc (GRCE) Implied Volatility Current

Tracking GRCE implied volatility helps you identify when options premiums on Grace Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Grace Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when GRCE IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Grace Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For GRCE, tracking metrics like GRCE IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on GRCE signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where GRCE implied volatility sits today versus where it has been. Our scanner ranks Grace Therapeutics Inc implied volatility against its historical range, surfaces extremes in GRCE IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Grace Therapeutics Inc IV is rich or cheap — measure it, then act on it.